Previous 10 | Next 10 |
After two consecutive sessions of double-digit losses, Longeveron (LGVN +9.1%) turned positive after announcing an agreement with two Japanese institutions to conduct a Phase 2 trial for Lomecel-B for older, frail subjects in the country. Per the sponsored clinical research agreement sig...
MIAMI, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions, announced today that it has entered into a sponsor...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Looking for a perfect biotech company with no problems whatsoever? Sorry, but Source: Shutterstock (NASDAQ: LGVN ) doesn’t fit that description. However, it’s definitely safe to say that LG...
Palm Beach, FL –November 30, 2021 – FinancialNewsMedia.com News Commentary – Atopic dermatitis is a chronic inflammatory skin condition characterized by red, itchy, swollen, and broken skin. White fluid can leak from the affected region, necessitating treatm...
Longeveron is the latest biotech "meme stock" like e.g. Brooklyn Immunotherapeutics, and RA Medical before it. The company's stock surged >$40 - from a price of ~$3 - as short sellers rushed to buy back stock after Longeveron secured a Rare Pediatric Disease designation. Longs ...
LGVN went up nearly 20x on a social media-created short squeeze. There's not a lot of medicine to back it all up. The stock will fall once those traders move on to another target. For further details see: Longeveron: Spooky Social-Media Generated Spike Signifies Nothing ...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. The world's stock markets plunged alongside oil prices and U.S. Treasury yields Friday after South Africa raised the alarm over a fast-spread...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Gainers: iSpecimen (NASDAQ:ISPC) +71%, Allied Healthcare Products (NASDAQ:AHPI) +68%, Adagio Therapeutics (NASDAQ:ADGI) +34%, Biofrontera (NASDAQ:BFRI) +31%, Moderna (NASDAQ:MRNA) +22%. Losers: Longeveron (NASDAQ:LGVN) -18%, IM Canna...
Are These The Best Health Care Stocks To Buy Right Now? Whether it is health care stocks , vaccine stocks, or telehealth stocks, investors appear to be eyeing the health care world. For the most part, this would be the case in the stock market today as Covid-19 appears to be ret...
News, Short Squeeze, Breakout and More Instantly...
Longeveron (NASDAQ: LGVN) , a clinical-stage, regenerative-medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, has closed on its previously announced registered direct offering. The offering, which was priced at-the-market ...
MIAMI, July 19, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today ann...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...